No Data
No Data
Emerging markets outlook: be cautious of a one-step decline in the Growth Market 250 index, will continue to search for double-digit stocks by elimination method.
In the current market situation, there is strong selling pressure to avoid risks, and the emerging markets saw a significant decline this week. The rise and fall rates during this period showed that while the Nikkei average fell by -4.67%, the growth market index fell significantly further by -9.62%, and the growth market 250 index fell by -10.36%. Looking back as far as the former Mothers Index, this marked the lowest decline rate since the week of January 1, 2022, of -10.61%. Similar to the primary market, the strong selling pressure to avoid risk is due to factors such as the rapid appreciation of the yen after the meeting of the central banks of Japan, the US and China, and growing concern about a recession in the US economy.
Kohjin Bio To Go Ex-Dividend On March 28th, 2025 With 14 JPY Dividend Per Share
August 2nd (Japan Standard Time) - $Kohjin Bio(177A.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 14 JPY dividend per share. The ex-dividend
Kojin Bio [Lockup Release Schedule]
Cozyn Bio <177A> estimated release shares: 4,165,000 shares (estimated) Release date: July 25, 2024 If the stock price is 1.5 times or more from the public offering price after the listing date, there may be a possibility of selling. Target shareholders: Estimated shares SMBC Business Development No.1 Investment Business Limited Liability Partnership: 100,000 shares Saitama Resona Bank No.2 Investment Business Union: 100,000 shares Takahito Nakamura: 2
Pay attention to the movements of Biotechnology which fell sharply over the weekend and the battle of the 200-day moving average in the Growth 250 Index.
- Pay attention to whether the emerging markets can maintain the level of the 200-day moving average this week, which seems to be more stable than the prime market, which is shaken by former President Trump's words and actions. We want to pay attention to whether both the Tokyo Growth Market Index and the Tokyo Growth 250 Index can maintain the level of the 200-day moving average. Although the Russell 2000 index, which was a stimulus material for the current emerging markets, has stopped rising, we believe that the small and mid-cap stocks will continue to be strong in the US market compared to the major stock price indices such as NY Dow and Nasdaq. - Focus of buying
Emerging market outlook: Pay attention to the battle of the growth 250 index on the 200-day line and the trend of the bio-related stock that plummeted over the weekend.
Despite the dominance of buying, emerging markets saw a slight decline on a weekly basis. During the same period, while the Nikkei Average fell by -2.74%, the growth market index fell by -0.10% and the growth market 250 index fell by -0.21%, making the emerging markets a steady market. After the holidays, the Russell 2000 index, which is composed mainly of small and medium-sized companies on the US market, continued to rise, which stimulated buying of leading stocks in the growth market and bio-related stocks. Tokyo Stock Exchange
Volume change rate ranking (9:00 am) - Lear, JIA, etc. ranked in.
* In the volume change rate ranking, you can understand the interests of market participants such as the trend of search by comparing the average volume of the last 5 days with the volume on the day of distribution. * Top volume change rate [as of 9:32 on July 18] (comparison with average volume of the last 5 days) Stock Code, Stock Name, Volume, 5-Day Average Volume, Volume Change Rate, Stock Price Change Rate <4579> Lear, 676,900, 107,185.08, 185.24%, 0.018
No Data